Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers

NCT07672574 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibrostenotic Crohn's Disease

Interventions

DRUG: Ontunisertib
DRUG: [14C]ontunisertib
DRUG: [14C]ontunisertib

Sponsor

Agomab Spain S.L.U.